1. Immune–inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective

   • Martin Kozel
   • Viktor Kočka
   • Petr Toušek

   Original Article 12 October 2018 Pages: 557 - 563

   

2. Frequency and prognostic impact of intravascular imaging-guided urgent percutaneous coronary intervention in patients with acute myocardial infarction: results from J-MINUET

   • Hiroyuki Okura
   • Yoshihiko Saito
   • The J-MINUET investigators

   Original Article 02 November 2018 Pages: 564 - 571

3. Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction

   • Hideki Yano
   • Shigeo Horinaka
   • Toshihiko Ishimitsu

   Original Article 03 November 2018 Pages: 572 - 582

   

4. The perfusion index is a useful screening tool for peripheral artery disease

   • Hiroshi Okada
   • Muhei Tanaka
   • Michiaki Fukui

   Original Article 03 October 2018 Pages: 583 - 589

   

5. Comparison of leg loader and treadmill exercise for evaluating patients with peripheral artery disease

   • Yasushi Ueki
   • Takashi Miura
   • Koichiro Kuwahara

   Original Article 04 October 2018 Pages: 590 - 596

   

6. Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

   • Hidekatsu Fukuta
   • Toshihiko Goto
   • Nobuyuki Ohte

   Original Article 12 October 2018 Pages: 597 - 606

   

7. Prognostic factors for long-term outcomes in acute decompensated heart failure patients under tolvaptan treatment

   • Koichiro Matsumura
   • Shun Morishita
   • Ichiro Shiojima

   Original Article 01 November 2018 Pages: 607 - 615

   

8. Impact of a prolonged interatrial conduction time for predicting the recurrence of atrial fibrillation after circumferential pulmonary vein isolation of persistent atrial fibrillation

   • Satoshi Higuchi
   • Koichiro Ejima
   • Nobuhisa Hagiwara

   Original Article 05 October 2018 Pages: 616 - 624

   

9. Prevalence of early repolarization syndrome and long-term clinical outcome in patients with the diagnosis of idiopathic ventricular fibrillation

   • Daniel Dalos
   • Lukas Fiedler
   • Christoph Schukro

   Original Article Open access 04 October 2018 Pages: 625 - 631

   

10. Radiofrequency catheter ablation prior to percutaneous coronary intervention in patients with atrial fibrillation coexisting with stable coronary artery disease: a single-center pilot study

    • Satoshi Kawada
    • Atsuyuki Watanabe
    • Hiroshi Ito

    Original Article 15 October 2018 Pages: 632 - 640

    

11. The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction

    • Hideki Koike
    • Toshisuke Morita
    • Takanori Ikeda

    Original Article 08 November 2018 Pages: 641 - 649

    

12. Electrocardiographic characteristics in the patients with a persistent left superior vena cava

    • Kanako Ito-Hagiwara
    • Yu-ki Iwasaki
    • Wataru Shimizu

    Original Article 12 October 2018 Pages: 650 - 657

    

13. ISL1 loss-of-function mutation contributes to congenital heart defects

    • Lan Ma
    • Juan Wang
    • Yi-Qing Yang

    Original Article 02 November 2018 Pages: 658 - 668

    

14. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry

    • Yuji Nishimoto
    • Yugo Yamashita
    • The COMMAND VTE Registry Investigators

    Original Article 06 October 2018 Pages: 669 - 677

    

15. Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer and/or older age

    • Daisuke Sato
    • Satoshi Ikeda
    • Koji Maemura

    Original Article 19 October 2018 Pages: 678 - 687

    

16. Increasing mixed venous oxygen saturation is a predictor of improved renal function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

    • Sarasa Isobe
    • Yuji Itabashi
    • Keiichi Fukuda

    Original Article 01 November 2018 Pages: 688 - 697

    

17. Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

    • Satoshi Imaizumi
    • Yuhei Shiga
    • ACADEMIE Study Investigators

    Original Article 08 November 2018 Pages: 698 - 710

    

18. Chronotropic incompetence to exercise in anorexia nervosa patients during the body-weight recovery phase as an index of insufficient treatment

    • Yu Yoshida
    • Jun Maeda
    • Mitsuaki Tokumura

    Original Article 19 October 2018 Pages: 711 - 715

19. Assessment of single beat end-systolic elastance methods for quantifying ventricular contractility

    • Naomi Wo
    • Vijay Rajagopal
    • Jonathan P. Mynard

    Original Article 14 November 2018 Pages: 716 - 723

    

20. Type 2 inositol 1,4,5-trisphosphate receptor inhibits the progression of pulmonary arterial hypertension via calcium signaling and apoptosis

    • Akimichi Shibata
    • Keiko Uchida
    • Hiroyuki Yamagishi

    Original Article 20 November 2018 Pages: 724 - 734